Safety and Tolerability of SHR-1918 in Healthy Subjects
Status:
Not yet recruiting
Trial end date:
2023-12-12
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the safety and tolerability of SHR-1918
injection in healthy subjects. In addition, this study will provide information on
pharmacokinetics and pharmacodynamics of SHR-1918 injection in healthy subjects.